C.-M. Cao

The inflammatory cytokine profile of myelodysplastic syndromes

Yanhua Zheng, Xiequn Chen, Xin Shi, 2019, Medicine.

Pharmacological inhibition of EZH2 combined with DNA-damaging agents interferes with the DNA damage response in MM cells

Yanhua Zheng, Juan Feng, Xiequn Chen, 2019, Molecular medicine reports.

Expression of miR-135a in cerebrospinal fluid of patients with tuberculous meningitis and its association with clinicopathological features

M. Jin, C.-M. Cao, Jun-hua Lin, 2020 .

Primary lymphoma of bone: a population-based study of 2558 patients

Pan-pan Wang, Yan-Hua Zheng, Li Xu, 2020, Therapeutic advances in hematology.

Rituximab-based combination therapy in patients with Waldenström macroglobulinemia: a systematic review and meta-analysis

Juan Feng, Yan-Hua Zheng, Li Xu, 2019, OncoTargets and therapy.

Clinicopathologic significance of S 100 A 4 expression in osteosarcoma

C.-M. Cao, P-L Wang, Q-X Yang, 2014 .

Clinicopathologic significance of S100A4 expression in osteosarcoma.

C.-M. Cao, P-L Wang, Q-X Yang, 2014, European review for medical and pharmacological sciences.

Distribution of lymphoid neoplasms in Northwest China: Analysis of 3244 cases according to WHO classification in a single institution.

Juan Feng, Xiequn Chen, Zhe Wang, 2017, Annals of diagnostic pathology.